Mofezolac
From Wikipedia, the free encyclopedia
Jump to: navigation, search
 |
|
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration |
Oral |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
|
|
| CAS Number | 78967-07-4  Y |
| PubChem (CID) | 4237 |
| ChemSpider | 4089 |
| UNII | RVJ0BV3H3Y Y |
| KEGG | D01718 Y |
| Chemical and physical data | |
| Formula | C19H17NO5 |
| Molar mass | 339.34 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Mofezolac (INN) is a non-steroidal anti-inflammatory drug.
References[edit]
| Pyrazolones / Pyrazolidines |
|
|---|---|
| Salicylates | |
| Acetic acid derivatives and related substances |
|
| Oxicams | |
| Propionic acid derivatives (profens) |
|
| N-Arylanthranilic acids (fenamates) |
|
| Coxibs | |
| Other | |
|
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications.
|
|
 |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mofezolac&oldid=713218519"
